|
End-of-day quote
NSE India S.E.
2026-09-01
|
5-day change | 1st Jan Change | ||
| 91.56 INR | -4.96% |
|
-8.91% | +30.80% |
| 08-10 | Valiant Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| 08-10 | Valiant Laboratories Limited Approves the Opening of New Corporate Office | CI |
Company Valuation: Valiant Laboratories Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2024 | 2025 |
|---|---|---|
| Market Cap 1 | 6,302 | 3,327 |
| Change | - | -47.2% |
| Enterprise Value (EV) 1 | 5,631 | 3,780 |
| Change | - | -32.87% |
| P/E | 1,725x | -150x |
| PBR | 2.66x | 1.42x |
| PEG | -17.4x | 0x |
| Capitalization / Revenue | 3.46x | 2.49x |
| EV / Revenue | 3.09x | 2.83x |
| EV / EBITDA | -65.5x | -77.6x |
| EV / EBIT | -54.3x | -55.8x |
| EV / FCF | -14.1x | -2.79x |
| FCF Yield | -7.11% | -35.9% |
| Dividend per Share 2 | - | - |
| Rate of return | - | - |
| EPS 2 | 0.0841 | -0.51 |
| Distribution rate | - | - |
| Net sales 1 | 1,821 | 1,334 |
| EBITDA 1 | -85.98 | -48.7 |
| EBIT 1 | -103.7 | -67.72 |
| Net income 1 | 3.196 | -22.01 |
| Net Debt 1 | -671.1 | 452.9 |
| Reference price 2 | 145.05 | 76.58 |
| Nbr of stocks (in thousands) | 43,450 | 43,450 |
| Announcement Date | 7/17/24 | 9/1/25 |
1INR in Million2INR
Estimates
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- VALIANTLAB Stock
- Valuation Valiant Laboratories Limited
Select your edition
All financial news and data tailored to specific country editions
